Back to Agenda
How Can We Compliantly Exchange Pre-Approval Information with Payers
Session Chair(s)
Sissi Pham, PharmD
Chief Executive Officer
AESARA, United States
Discuss the practical challenges with interpretation aspects of the FDA Payer guidance released in 2018 for pre-approval communications and and possible operationalization considerations.
Learning Objective : Describe how we can proactively and compliantly communicate during pre-approval phase relevant coverage and reimbursement information from industry to payers for population-based coverage decisions.
Speaker(s)
Industry Perspective
Stephen Shinall, PhD
Biogen, United States
Director of Regulatory Affairs
Industry Update
Susan A Cantrell, RPh
Academy of Managed Care Pharmacy (AMCP), United States
Chief Executive Officer
Industry Update
Lucy Rose, MBA
Lucy Rose and Associates, United States
President
Have an account?